Best practice in therapeutic drug monitoring
- PMID: 9723816
- PMCID: PMC1873661
- DOI: 10.1046/j.1365-2125.1998.00770.x
Best practice in therapeutic drug monitoring
Abstract
It is the goal of Therapeutic Drug Monitoring (TDM) to use drug concentrations to manage a patient's medication regimen and optimise outcome. Limited resources require that drug assays should only be performed when they do contribute to patient management. For this to be the case a therapeutic drug monitoring service has a far greater role than just therapeutic drug measuring. This article describes the roles and functions of a Best Practice TDM service. The features which can and should be strived for in each step of the TDM process-the decision to request a drug level, the biological sample, the request, laboratory measurement, communication of results by the laboratory, clinical interpretation and therapeutic management-are discussed.
Figures
Comment in
-
Target concentration intervention: beyond Y2K.Br J Clin Pharmacol. 1999 Jul;48(1):9-13. doi: 10.1046/j.1365-2125.1999.00971.x. Br J Clin Pharmacol. 1999. PMID: 10383553 Free PMC article.
References
-
- Levy G, Ebling WF, Forrest A. Concentration- or effect-controlled clinical trials with sparse data. Clin Pharmacol Ther. 1994;56:1–8. - PubMed
-
- Campbell M. Community-based therapeutic drug monitoring. Clin Pharmacokinet. 1995;28:271–274. - PubMed
-
- Birkett DJ. Therapeutic drug monitoring. Australian Prescriber. 1997;20:9–11.
-
- Spector R, Park GD, Johnson G, et al. Therapeutic drug monitoring. Clin Pharmacol Ther. 1988;43:345–353. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
